Abstract:Hongzhi Hu, 1, * Shangyu Wang, 1, * Deyao Shi, 1 Binglong Zhong, 1 Xin Huang, 1 Chunwei Shi, 2 Zengwu Shao 1 1 Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, People's Republic of China; 2 Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, People's Republic of China *These authors contributed equally to this work Background: Lycorine, a natural alkaloid, has been indicated to have various physiological effects, including a potential effect against cancer. However, the anticancer effect of lycorine on osteosarcoma (OS) and the detailed molecular mechanisms involved remain unclear. Purpose: The purpose of this study was to examine the effect of lycorine on human OS and elucidated it underlying mechanisms Materials and methods: In vitro assays, OS cells were treated with lycorine at various concentrations. Then the cell proliferation, colony formation, cell cycle distribution, apoptosis, migration and invasion were assayed to detect the anticancer effect of lycorine on OS cell lines. Western blotting analysis was used to verify the expression of related proteins. In addition, the mouse xenograft model was performed to evaluate lycorine's therapeutic potential on OS in vivo. Results: The in vitro results demonstrated that lycorine induced apoptosis and cell cycle arrest and suppressed the migration and invasion by suppressing constitutive signal transducers and activators of transcription 3 (STAT3) activation through enhancing the expression of SH2 domain-containing phosphatase 1 (SHP-1) and downregulating the expression of STAT3 target proteins. Moreover, our mouse xenograft model revealed that lycorine inhibited the tumor growth in vivo. Conclusion: These results demonstrated that the anti-OS effects of lycorine were at least partly due to the suppression of the Janus kinase 2/signal transducers and activators of transcription 3 (JAK2)/STAT3 pathway. Taken together, these results indicate that lycorine possesses the potential to be a promising candidate in clinical therapy for human OS in the future. Keywords: lycorine, osteosarcoma, anticancer, SHP-1, JAK2/STAT3

Costunolide inhibits osteosarcoma growth and metastasis via suppressing STAT3 signal pathway

Costunolide Inhibits Matrix Metalloproteinases Expression and Osteoarthritis Via the NF‑κB and Wnt/β‑catenin Signaling Pathways.

T52 Attenuates Oncogenic STAT3 Signaling and Suppresses Osteosarcoma.

Osteosarcoma cell proliferation suppression via SHP-2-mediated inactivation of the JAK/STAT3 pathway by tubocapsenolide A

Pectolinarigenin Acts As a Potential Anti-Osteosarcoma Agent Via Mediating SHP-1/JAK2/STAT3 Signaling.

Toosendanin Demonstrates Promising Antitumor Efficacy in Osteosarcoma by Targeting STAT3

the effects of costunolide on cell viability, the cell cycle and apoptosis in SK-MES-1 human lung squamous carcinoma cells were investigated. Costunolide induced morphological changes and inhibited growth of SK-MES-1 cells growth. Flow cytometric analysis data demonstrated that costunolide significa

Telocinobufagin inhibits osteosarcoma growth and metastasis by inhibiting the JAK2/STAT3 signaling pathway.

Salidroside suppresses the growth and invasion of human osteosarcoma cell lines MG63 and U2OS in vitro by inhibiting the JAK2/STAT3 signaling pathway

Telocinobufagin inhibits osteosarcoma growth and metastasis by inhibiting the JAK2/STAT3 signaling pathway

Lycorine exerts antitumor activity against osteosarcoma cells in vitro and in vivo xenograft model through the JAK2/STAT3 pathway

RETRACTED ARTICLE: Natural Product Pectolinarigenin Inhibits Osteosarcoma Growth and Metastasis Via SHP-1-mediated STAT3 Signaling Inhibition

Costunolide is a dual inhibitor of MEK1 and AKT1/2 that overcomes osimertinib resistance in lung cancer

Sinomenine prevents metastasis of human osteosarcoma cells via S phase arrest and suppression of tumor-related neovascularization and osteolysis through the CXCR4-STAT3 pathway

Oxyresveratrol Reduces the Migration of Human Osteosarcoma Cell U2OS Via Attenuating STAT3 Activation

Role of crosstalk between STAT3 and mTOR signaling in driving sensitivity to chemotherapy in osteosarcoma cell lines

STAT3 Activation by IL-6 from Mesenchymal Stem Cells Promotes the Proliferation and Metastasis of Osteosarcoma.

Chloroquine Suppresses Proliferation and Invasion and Induces Apoptosis of Osteosarcoma Cells Associated with Inhibition of Phosphorylation of STAT3

Diosmetin Inhibits Cell Proliferation and Promotes Apoptosis Through STAT3/c-Myc Signaling Pathway in Human Osteosarcoma Cells.

Costunolide suppresses an inflammatory angiogenic response in a subcutaneous murine sponge model

Psoralidin inhibits osteosarcoma growth and metastasis by downregulating ITGB1 expression via the FAK and PI3K/Akt signaling pathways